Hong Kong
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 23.55
|
Dec. 31, 2023 | USD 17.19 | 2.12% |
|
Hong Kong |
|
2 |
USD 5.51
|
Dec. 31, 2023 | USD 0.67 | 1.15% |
|
Hong Kong |
|
3 |
USD 1.93
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
4 |
USD 1.07
|
Dec. 31, 2023 | USD 1.48 | 0.68% |
|
Hong Kong |
|
5 |
USD 0.99
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
6 |
USD 0.51
|
Dec. 31, 2023 | USD 0.25 | -2.07% |
|
Hong Kong |
|
7 |
USD 0.46
|
Dec. 31, 2023 | USD 0.93 | 2.39% |
|
Hong Kong |
|
8 |
USD 0.43
|
Dec. 31, 2023 | USD 0.52 | 0.23% |
|
Hong Kong |
|
9 |
USD 0.28
|
Dec. 31, 2023 | USD 0.41 | 0.30% |
|
Hong Kong |
|
10 |
USD 0.28
|
Dec. 31, 2023 | USD 0.80 | 2.57% |
|
Hong Kong |
|
11 |
USD 0.27
|
March 31, 2024 | USD 0.46 | 4.31% |
|
Hong Kong |
|
12 |
USD 0.23
|
Dec. 31, 2023 | USD 1.07 | 3.09% |
|
Hong Kong |
|
13 |
USD 0.23
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
14 |
USD 0.21
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
15 |
USD 0.20
|
Dec. 31, 2023 | USD 0.43 | -0.61% |
|
Hong Kong |
|
16 |
USD 0.18
|
Dec. 31, 2023 | USD 0.44 | 1.16% |
|
Hong Kong |
|
17 |
USD 0.16
|
Dec. 31, 2023 | USD 0.38 | 2.08% |
|
Hong Kong |
|
18 |
USD 0.14
|
March 31, 2024 | USD 0.27 | 0.46% |
|
Hong Kong |
|
19 |
USD 0.13
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
20 |
USD 0.11
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
21 |
USD 0.01
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
|
22 |
USD 0.00
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
23 |
USD 0.00
|
June 30, 2024 | USD 3.80 | 0.53% |
|
Hong Kong |
The Healthcare company in Hong Kong with the highest Revenue Per Share is BeiGene, Ltd. (HKSE: 6160.HK) at USD 23.55.
The Healthcare company in Hong Kong with the lowest Revenue Per Share is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD 0.00.
The top 10 Healthcare companies in Hong Kong by Revenue Per Share are BeiGene, Ltd., China Resources Pharmaceutical Group Limited, Prenetics Global Limited, The United Laboratories International Holdings Limited, HUTCHMED (China) Limited, China Traditional Chinese Medicine Holdings Co. Limited, China Medical System Holdings Limited, Modern Dental Group Limited, SSY Group Limited and Guangdong Hybribio Biotech Co.,Ltd..
The bottom 10 Healthcare companies in Hong Kong by Revenue Per Share are Regencell Bioscience Holdings Limited, SinoMab BioScience Limited, Sirnaomics Ltd., Dawnrays Pharmaceutical (Holdings) Limited, Frontage Holdings Corporation, Perfect Medical Health Management Limited, Sino Biopharmaceutical Limited, OrbusNeich Medical Group Holdings Limited, Tycoon Group Holdings Limited and Jilin Province Huinan Changlong Bio-pharmacy Company Limited.